Category Archives: Media

Canary Party’s False Promises Led To Congressional Hearing Collapse

Hooker-Larson comment

(Click to enlarge)

By Jake Crosby

Above is a screenshot dated March 23rd of a Facebook post from Dr. Brian Hooker asking for people to call congressional staff and ask that the Congressional Committee on Oversight & Government Reform (COGR) specifically investigate data fraud committed by CDC to cover up the vaccine-autism link. Commenting beneath his Facebook post is none other than Jennifer Larson – President of the Canary Party:

“We are on it! Thanks Brian Hooker!”

But after weeks of planning a Canary Party Action Alert that was intended to support Brian Hooker’s investigation, suddenly Canary Party sent out an alert that did not represent what was promised to him:

“Chairman Issa stated there is nothing that is off-limits for what the OGR committee will continue to explore. Ask him to promptly schedule the next hearing to investigate government malfeasance in covering up the vaccine/autism connection including, as examples, the following areas:

• Evidence in the National Vaccine Injury Compensation Program showing clearly that vaccines can and do cause autism

• CDC’s cover-up of the thimerosal/autism connection

• CDC’s suppression of evidence of the autism epidemic”

This Action Alert reveals Canary Party’s strategy to shift the topic away from CDC’s cover-up of the thimerosal/autism connection. In the first bullet point, the Canary Party introduces NVICP as evidence that vaccines cause autism. Somehow, NVICP as evidence of vaccines’ link to autism later morphed into NVICP reform – the new topic for the next congressional hearing. But what happened to the topic promised to Dr. Hooker?

Not only was the CDC cover-up of thimerosal’s role in causing the autism epidemic buried in the middle of the Action Alert, but the wording was clearly favorable to the entirely different topic of NVICP. In fact, that was exactly what Canary Party’s Executive Director Patti Carroll asked for in a long letter she posted on the House Committee on Oversight & Government Reform’s Facebook page. And now, Canary Party claims NVICP was Issa’s idea all along, even though we can trace its origin to the above Action Alert.

Brian Hooker was not pleased with this turn of events and wrote on Facebook, “COGR is not ready for that investigation and I’ve been told by their staff many times that they do not yet have energy for the NVICP. We are so close to a CDC investigation. That is why I approached Jennifer about the Action Alert. The message is now confused. I’m very discouraged…”

Regarding the action alert specifically, Dr. Hooker commented:

“not effective… not what I talked to Jennifer about… very discouraged…”

He then expressed regret about the action alert entirely:

“If I would have know [sic] this, I would have withdrawn my request for an action alert.”

Sure enough, the December-scheduled NVICP hearing Canary Party requested (in violation of its promise to Dr. Brian Hooker) was cancelled. Without providing any direct quotes from those who cancelled the hearing , Canary Party immediately shifted blame on everything from interference by the vaccine industry to simply “poor timing”. The below quote from a legal source in direct contact with COGR Chairman Issa’s counsel, previously disclosed on Autism Investigated, tells an entirely different story:

“I was just informed by the Counsel for Chairman Issa that due to ‘great deal of reluctance about participating or being drawn into what they, in their private candid discussions with us, say they see as an overly divisive issue’ they are canceling the hearing.”

Certainly it was divisive of Canary Party to promise one thing and then suddenly deliver something else that aims to avoid the CDC’s suppression of evidence thimerosal causes autism. Similarly, it was divisive of Canary Party to misrepresent a vaccine-injured child’s case at its congressional briefing and then when her mother complained in the comments of the Canary Party-sponsored/edited Age of Autism blog, approve a barrage of anonymous attacks from commenters including one from an organizer of the briefing. Put them both together and the result is an overly divisive issue Congress is reluctant to touch.

At least three questions remain unanswered: Why did Canary Party introduce a new hearing topic when Brian Hooker was so close to exposing CDC malfeasance that legislators were grilling a top CDC official about vaccine safety? Why did Canary Party instead push for a topic that COGR has stated many times it is not ready to pursue? Lastly, why are members of the autism community still following the Canary Party?

Jake Crosby is editor of Autism Investigated. He is a 2011 graduate of Brandeis University with a Bachelor of Arts in both History and Health: Science, Society and Policy and a 2013 graduate of The George Washington University School of Public Health and Health Services with a Master of Public Health in Epidemiology. He currently attends the University of Texas School of Public Health where he is studying for a Ph.D. in Epidemiology.

 

Vaccine Industry Watchdog Responds to Forbes Defense of Mercury-Laced Vaccinations

BRIAN HOOKER, PHD, PE

Dr. Brian Hooker, PhD, says Forbes misrepresented congressional records and CDC studies

CHARLOTTE, N.C., Feb. 28, 2014 /PRNewswire-iReach/ — Last week, PhD biochemist Brian Hooker created a stir when he announced he had obtained sensitive documents from the CDC (Centers for Disease Control and Prevention) through Freedom of Information Act (FOIA) requests. According to Hooker, these documents implicated the vaccine preservative Thimerosal (50% mercury by weight) in causing autism and other neurodevelopmental disorders, revealing what he says CDC officials had long known, but never disclosed publicly: a 7.6-fold increase in autism during infancy after exposure. Emily Willingham, who frequently editorializes in support of the vaccine program, responded in Forbes by criticizing a news story that went viral on the subject of Dr. Hooker’s FOIA revelations.

(Photo: http://photos.prnewswire.com/prnh/20140228/MN73622)

Dr. Hooker methodically itemized “misrepresentations and outright errors” that he says appeared in Forbes.com. “Willingham either confused two CDC studies or intentionally deceived Forbes’ readers,” said Hooker. “There was one concealed study that found a very high association between Thimerosal and autism. That was the study that was kept from the public which I obtained. And there was a later study by the same researcher – CDC-paid epidemiologist Thomas Verstraeten – who had watered down the results of the earlier study to appear as if there were no association between Thimerosal and autism. That second study was made public even though it was fraudulent.  Willingham pointed to the conclusions of the later study and implied that they came from the earlier study.”

Although Willingham denies that the CDC researcher, Dr. Verstraeten, was under pressure to alter the results of the earlier study, Dr. Hooker points out that Verstraeten’s own email written at the time (an internal CDC document obtained through FOIA) reveals otherwise. Verstraeten’s subject line, “It just won’t go away,” refers to his difficulty in making the statistical association between Thimerosal and autism disappear.

Making an example of how he says Dr. Verstraeten hid that association in his reanalysis of the data on 400,000 infants, Dr. Hooker says Verstraeten did not include clinics within HMOs where there was a strong correlation between Thimerosal exposure and autism incidence. According to Hooker, “Willingham brazenly disregarded Verstraeten’s own chilling words: ‘All the harm is done in the first month [of life]…’ He wrote those words about the study I obtained.”  The abstracts of Verstraeten’s two studies and further comment on the controversy can be viewed here.

Dr. Hooker says Willingham misrepresented the congressional record when she selected quotes from a 2007 U.S. Senate report which falsely asserted that allegations of a cover-up are unsubstantiated. He considers the U.S. House of Representatives’ 2003 report titled Mercury in Medicine (the result of a 3-year investigation) a “scathing, 80-page indictment of the CDC regarding the Thimerosal coverup.”  The report concludes, “Our public health agencies’ failure to act is indicative of institutional malfeasance for self-protection and misplaced protectionism of the pharmaceutical industry.”

Willingham treated Verstraeten’s final, watered-down results as solid epidemiological evidence, when, according to Hooker, the final version of the Verstraeten study is fraught with statistical flaws, primarily “overmatching.” He provided an example:  the cases and controls received the same vaccination schedule and the same Thimerosal dosage; thus, no true comparison could be made.  Hooker says this invalidates all of the analyses (done separately for HMOs A, B and C).

Willingham quoted Verstraeten’s  2004 letter in the journal Pediatrics regarding his later, diluted study, omitting the fact that the CDC has used the study to exonerate Thimerosal despite Verstraeten calling the study “neutral.”  In addition, the 2004 Institute of Medicine (IOM) Immunization Safety Review (ISR) committee report used this as the only U.S. epidemiological study (among the 5 studies) as the basis to reject the Thimerosal-autism hypothesis, shutting the door on any further research.

“In light of Ms. Willingham’s enthusiastic defense of mercury in vaccines despite conclusive evidence of its harm to children, it is ironic that the tagline for her column is ‘I write about the science they are selling you.'” remarked Dr. Hooker. Thimerosal is still administered to pregnant women and infants via the flu shot.

Brian Hooker, PhD, PE is an associate professor of biology at Simpson University. His over 50 science and engineering papers have been published in internationally recognized, peer-reviewed journals. He has a son, aged 16, who developed normally but then regressed into autism after receiving Thimerosal-containing vaccines. Dr. Brian Hooker’s investigative research is sponsored by the Focus Autism Foundation, which is dedicated to informing the public about the cause(s) of the autism epidemic and the rise of chronic illnesses. To learn more, visit focusautisminc.org and ashotoftruth.org,  an educational website sponsored by Focus Autism.

AutismOne is co-sponsoring this message and is a non-profit 501(c)(3) organization that provides education and supports advocacy efforts for children and families touched by an autism diagnosis. To learn more, visit autismone.org.

Media Contact: Angela Medlin, A Shot of Truth, 1 866-498-2768, angela@ashotoftruth.org

News distributed by PR Newswire iReach: https://ireach.prnewswire.com

 

SOURCE Brian Hooker, PhD, PE

RELATED LINKS
http://www.ashotoftruth.org

Forbes’ Emily Willingham Pretends CDC Study Results Don’t Exist

Editor’s Note: Click the above image to enlarge.

By Jake Crosby

Forbes’ writers seem to have trouble reading scientific abstracts. In December, its senior editor Matthew Herper cited a press release that contradicted the research he discussed to endorse the vaccine efficacy of Gardasil. That, however, pales in comparison to the type of misrepresentation contributor Emily Willingham made when she conflated an earlier, suppressed CDC analysis (left abstract in image) showing thimerosal is associated with autism with a later, watered-down analysis CDC distributed at a public meeting that showed no association (right abstract in image). All the more remarkable is that she is an autism parent herself and has a PhD in biology.

Following the press release by Focus Autism, AutismOne and A Shot of Truth about the earlier abstract uncovered by A Shot of Truth scientific advisor Dr. Brian Hooker, Willingham responded with a long and verbose article titled, “Is The CDC Hiding Data About Mercury, Vaccines, and Autism?” She then answered her own title with: “You know the rule. The answer is, ‘No.'”

One paragraph in, she was already getting basic facts of the abstract disastrously wrong: “In 1999, four authors affiliated with the CDC presented an abstract at a conference … a CDC conference for fellows of its Epidemic Intelligence Service (EIS).” The conference takes place annually in April, but the research project of thimerosal did not even begin until August of that year as pointed out by chemist and Coalition for Mercury-Free Drugs‘ secretary Dr. Paul King in a comment to me. That error of Willingham’s, however, could hardly have predicted what was to come.

Although she never linked to the abstract from her article, she did read it and quoted directly from it – noting that it compared a “highest exposure group” to an “unexposed group”. Though she acknowledged the study authors “reported an increased risk for nondegenerative neurological disorders,” she never acknowledged they included autism.

Then five paragraphs into her article she suddenly switched from talking about the long-suppressed abstract to talking about a later analysis  where no comparison of autism across highest-and-unexposed groups was included. The manuscript describing that analysis, dated June 1st, 2000, was presented at the closed Simpsonwood meeting of federal officials and pharmaceutical industry representatives the following week and then distributed by CDC at a public meeting of the Advisory Committee on Immunization Practices later that same month. That document Willingham cited was not concealed from the public for over a decade and did not show that thimerosal is associated with autism, unlike the abstract of the earlier analysis. Yet she spent the rest of her article discussing the later study as if it was the same CDC study cited in the press release circulated by Focus Autism, AutismOne and A Shot of Truth and later picked up by Health Impact News Daily whose headline she drew attention to.

She even quoted the lead investigator Dr. Thomas Verstraeten presenting the lack of association with autism in the later manuscript:

“This is the result for autism, in which we don’t see much of a trend except for a slight, but not significant, increase for the highest exposure. The overall test for trend is statistically not significant.”

Dr. Verstraeten was under considerable pressure to reanalyze the data to  make the association between thimerosal and neurological disorders disappear, as evidenced in an email he titled “It just won’t go away.”  He wrote “…some of the RRs [relative risks] increase over the categories and I haven’t yet found an alternative explanation… Please let me know if you can think of one.” He and his colleagues issued successive studies  watering down the original results and ultimately, as  Willingham conceded, he was hired by vaccine maker GlaxoSmithKline.

What Willingham never quoted, however, was the reported result for autism in the abstract of the earlier analysis that the press release was actually about:

“The relative risk (RR) of developing a neurologic development disorders was 1.8 (95% confidence intervals [CI] = 1.1-2.8) when comparing the highest exposure group at 1 month of age (cumulative dose  > 25 ug) to the unexposed group. Within this group we also found an elevated risk for the following disorders: autism (RR 7.6, 95% CI = 1.8-31.5), nonorganic sleep disorders (RR 5.0, 95% CI = 1.6-15.9), and speech disorders (RR 2.1, 95% CI=1.1-4.0).”

Apparently, Willingham is imitating CDC, as all the way back in 2004 one of the coauthors of both CDC analyses Dr. Frank DeStefano said in a presentation to the Institute of Medicine (IOM) that:

“In no analyses were significant increased risks found for ADD or autism”

In that same presentation, DeStefano also claimed the “Initial” analysis was a study dated February, 29th, 2000, where the association with autism originally reported in the suppressed abstract was apparently diluted away by combining the highest exposure category with a lower exposure category. The very existence of the positive research results from the long-suppressed study abstract was denied.

One decade later and Emily Willingham and Forbes Magazine are now following CDC’s lead, as are other vaccine industry talking heads.

Jake Crosby is editor of Autism Investigated. He is a 2011 graduate of Brandeis University with a Bachelor of Arts in both History and Health: Science, Society and Policy and a 2013 graduate of The George Washington University School of Public Health and Health Services with a Master of Public Health in Epidemiology. He currently attends the University of Texas School of Public Health where he is studying for a Ph.D. in Epidemiology.

Vaccine Industry Watchdog Obtains CDC Documents That Show Statistically Significant Risks of Autism Associated with Vaccine Preservative Thimerosal

gI_134518_3_logos

Biochemist Brian Hooker, scientific advisor to A Shot of Truth, reveals CDC knew of risks for over decade.

Charlotte, NC (PRWEB) February 19, 2014

For nearly ten years, Brian Hooker has been requesting documents that are kept under tight wraps by the Centers for Disease Control and Prevention (CDC). His more than 100 Freedom of Information Act (FOIA) requests have resulted in copious evidence that the vaccine preservative Thimerosal, which is still used in the flu shot that is administered to pregnant women and infants, can cause autism and other neurodevelopmental disorders.

Dr. Hooker, a PhD scientist, worked with two members of Congress to craft the letter to the CDC that recently resulted in his obtaining long-awaited data from the CDC, the significance of which is historic. According to Hooker, the data on over 400,000 infants born between 1991 and 1997, which was analyzed by CDC epidemiologist Thomas Verstraeten, MD, “proves unequivocally that in 2000, CDC officials were informed internally of the very high risk of autism, non-organic sleep disorder and speech disorder associated with Thimerosal exposure.”

When the results of the Verstraeten study were first reported outside the CDC in 2005, there was no evidence that anyone but Dr. Verstraeten within the CDC had known of the very high 7.6-fold elevated relative risk of autism from exposure to Thimerosal during infancy. But now, clear evidence exists. A newly-acquired abstract from 1999 titled, “Increased risk of developmental neurologic impairment after high exposure to Thimerosal containing vaccine in first month of life” required the approval of top CDC officials prior to its presentation at the Epidemic Intelligence Service (EIS) conference. Thimerosal, which is 50% mercury by weight, was used in most childhood vaccines and in the RhoGAM® shot for pregnant women prior to the early 2000s.

The CDC maintains there is “no relationship between Thimerosal-containing vaccines and autism rates in children,” even though the data from the CDC’s own Vaccine Safety Datalink (VSD) database shows a very high risk. There are a number of public records to back this up, including this Congressional Record from May 1, 2003. The CDC’s refusal to acknowledge thimerosal’s risks is exemplified by a leaked statement from Dr. Marie McCormick, chair of the CDC/NIH-sponsored Immunization Safety Review at IOM. Regarding vaccination, she said in 2001, “…we are not ever going to come down that it [autism] is a true side effect….” Also of note, the former director of the CDC, which purchases $4 billion worth of vaccines annually, is now president of Merck’s vaccine division.

Dr. Hooker’s fervent hope for the future: “We must ensure that this and other evidence of CDC malfeasance are presented to Congress and the public as quickly as possible. Time is of the essence. Children’s futures are at stake.” A divide within the autism community has led to some activists demanding that compensation to those with vaccine-injury claims be the top priority before Congress. Dr. Hooker maintains that prevention, “protecting our most precious resource – children’s minds,” must come first. “Our elected officials must be informed about government corruption that keeps doctors and patients in the dark about vaccine risks.”

Referring to an organization that has seen its share of controversy this past year, Dr. Hooker remarked, “It is unfortunate that SafeMinds issued a press release on my information, is accepting credit for my work and has not supported a worldwide ban on Thimerosal.”

Brian Hooker, PhD, PE, has 15 years experience in the field of bioengineering and is an associate professor at Simpson University where he specializes in biology and chemistry. His over 50 science and engineering papers have been published in internationally recognized, peer-reviewed journals. Dr. Hooker has a son, aged 16, who developed normally but then regressed into autism after receiving Thimerosal-containing vaccines.

Dr. Brian Hooker’s investigative research is sponsored by the Focus Autism Foundation.

The Focus Autism Foundation is dedicated to providing information to the public that exposes the cause or causes of the autism epidemic and the rise of chronic illnesses – focusing specifically on the role of vaccinations. To learn more, visit focusautisminc.org.

A Shot of Truth is a non-profit 501(c)(3) organization and educational website sponsored by Focus Autism.

AutismOne is a non-profit 501(c)(3) organization that provides education and supports advocacy efforts for children and families touched by an autism diagnosis. To learn more, visit autismone.org.

Originally posted on PRWeb.

Correction: As Coalition for Mercury-Free Drugs‘ Dr. Paul King pointed out, the year 1999 on the abstract specifies the year its lead investigator Thomas Verstraeten joined the EIS, but not the year of the abstract itself. The EIS conference the study authors planned to submit their abstract to took place during the year 2000.

SafeMinds Summed Up In One Comment

safemindscomment

By Jake Crosby

In a now-deleted comment I recently left under a press release posted by Lyn Redwood on the SafeMinds website that tried to take credit for uncovering suppressed CDC evidence for thimerosal causing autism, I wrote:

David Geier discovered the “Generation Zero” data, Lyn, not anyone at SafeMinds. Similarly, these “new disclosures” have already been publicly available on the CoMeD site for months. That you’re linking to it now does not make it “new.” In fact, none of the discovered CDC data showing statistically significant associations between thimerosal exposure and autism has ever been discovered by anyone at SafeMinds. Those who actually have discovered these research results have either been excluded from testifying before Congress by SafeMinds or been excluded from testifying in the omnibus autism proceeding on behalf of petitioners, also by SafeMinds.

SafeMinds never exposed the thimerosal cover-up, but rather is a part of it. In the weeks leading up to the 2012 congressional hearing, Lyn Redwood wrote in an email that it makes her “crazy” that Andrew Wakefield is crucified and Danish fugitive Poul Thorsen evades justice. Yet right after she said this, she gave up her speaking slot to a man who went to absurd lengths to falsely play down Thorsen’s role in the fraud that sought to exonerate thimerosal.  She backed out on the excuse she was picking up her son from his first college quarter, even though it ended two weeks before the hearing. She later claimed she was “very sad” Thorsen was not mentioned in SafeMinds’ congressional testimony before Congress, even though her actions led to Thorsen not being mentioned.

Now Lyn Redwood is announcing the release of this latest CDC information without crediting its discoverer, Dr. Brian Hooker.

Jake Crosby is editor of Autism Investigated. He is a 2011 graduate of Brandeis University with a Bachelor of Arts in both History and Health: Science, Society and Policy and a 2013 graduate of The George Washington University School of Public Health and Health Services with a Master of Public Health in Epidemiology. He currently attends the University of Texas School of Public Health where he is studying for a Ph.D. in Epidemiology.

Mark Blaxill’s Thimerosal Backtrack: An Act To Throw The Omnibus?

actIIthecurtainpostomnibus

By Jake Crosby

Following the disclosure of emails on Autism Investigated in which Mark Blaxill responded to the lead omnibus attorney in vaccine court with attacks on expert witnesses Dr. Mark and David Geier, Autism Investigated reader John Best made an astute observation about the attorney’s email. Within that email, the attorney wrote:

“…we realize that we have to  deal with the fact that the increase has continued beyond the removal of thimerosal, but we have to convince the Special Masters that something in the environment, perhaps several somethings, is triggering symptoms of ASD in many kids.”

To which John Best responded in a comment:

“The lawyers claimed they had to account for the increase [in autism] after thimerosal was all gone and that they had to blame something in the environment. So, the lawyers admitted right there that they were throwing the case intentionally. Too bad the statute of limitations for legal malpractice has passed. Those words are all that are needed to hang them.
Did they think the whole world was too stupid to know that shooting 25 mcg of thimerosal into pregnant women equated to 200 times the alleged “safe” dose of mercury?
Jake, you should have entitled this: Lawyers Admit Throwing Case.”

To which I responded:

“That was almost certainly Mark Blaxill’s doing:
http://www.autisminvestigated.com/mark-blaxill-danish-fraudulent/

He claimed to change his views in a 2007 email to Dr. Brian Hooker based on the premature conclusion that reported autism prevalence still going up in California was evidence against thimerosal’s role in the autism epidemic, yet also cited the very Danish numbers Blaxill once called “uninformative and potentially misleading” to defend thimerosal right after being informed of their fraudulent nature by Dr. Hooker. What this would suggest is that Blaxill’s representation of himself as a leading proponent of thimerosal’s significance in causing the autism epidemic only to backtrack from his position later was all just an act to sink the omnibus and strike a PR victory for pharma.”

The latest component of this act that I did not mention in the above comment, however, is Blaxill’s downplaying of harm from thimerosal and vaccines in general. Neither was mentioned in Mark Blaxill’s speech before Congress, nor are they in the mission statement of the Canary Party that he chairs and founded. Such minimization of thimerosal’s harm helps prevent some of the worst perpetrators of the thimerosal cover-up from facing justice for burying evidence of its role in causing the autism epidemic. And the lead actor pretends to have no ties to the pharmaceutical industry when he still does.

It is about time someone drew the curtain on his act.

Jake Crosby is editor of Autism Investigated and is diagnosed with an autism spectrum disorder. He is a 2011 graduate of Brandeis University with a Bachelor of Arts in both History and Health: Science, Society and Policy and a 2013 graduate of The George Washington University School of Public Health and Health Services with a Master of Public Health in Epidemiology. He currently attends the University of Texas School of Public Health where he is studying for a Ph.D. in Epidemiology.

Mark Blaxill Remains Connected To BCG – A Pharma-Tied Consulting Firm

boston_consulting_group

By Jake Crosby

Revelations about Mark Blaxill’s ties to his former employer the Boston Consulting Group (BCG) and its pharmaceutical clients – in contradiction to what he said in a recently recorded interview on Linderman Unleashed – have now come to the attention of Autism Investigated. These discoveries were made on the heels of even more troubling evidence coming to light: see the previous post about Mark Blaxill turning the lead omnibus attorneys against expert witnesses Dr. Mark and David Geier with baseless and profane attacks against them.

In spite of Mark Blaxill claiming on Linderman Unleashed that he was fired from the BCG – suggesting his autism advocacy played a role – he appears to have voluntarily left the firm for the purpose of starting his own company and for reasons wholly unrelated to autism. In fact, Blaxill still maintains ties to BCG despite no longer being employed with the firm as Senior Vice President and despite claiming he no longer has a conflict of interest “of any kind.” Blaxill also falsely claimed to have always consulted for non-pharmaceutical clients while a BCG executive, merely admitting the firm had pharmaceutical clients but he in fact concealed from Linderman’s audience that he had consulted for Merck during his BCG employment.

Here’s the story he gave on his podcast interview with Curt Linderman, dated October 24, 2013, regarding his BCG departure:

“And then in 2006 – early in 2006 not very long after Evidence of Harm came out – all of a sudden I found myself without a job, and I was no longer at the Boston Consulting Group…I did have issues that concerned me, and it actually didn’t stop me from speaking out, Curt, but it did worry me a little, and who knows? Maybe my worries were founded because I’m not working there anymore, and that was not my choice.”

However, the book Lords of Strategy: The Secret Intellectual History of the New Corporate World by Walter Kiechel tells a story about Mark Blaxill’s departure from Boston Consulting Group (BCG) that totally contradicts what Blaxill told Linderman. According to Kiechel:

“Blaxill wanted to push on to the issue of motivation, of why people worked on Linux for free, even into issues of creativity, but couldn’t find the time or support within the firm for exploring those dimensions. “The antibodies resisted that,” he says. In 2006, Blaxill left BCG to set up his own firm, 3LP Advisors, to concentrate on the intersection of strategy, intellectual property, and innovation.”  

In his interview on Linderman, Blaxill said 3LP Advisors was founded as a result of his firing from Boston Consulting Group, claiming the termination of his employment “was not my choice.” Yet not only was it his choice according to Kiechel, but in fact Blaxill left Boston Consulting Group so that he could found 3LP Advisors to practice his own business strategy the way he liked – nothing to do with autism.

Linderman then further questioned Blaxill specifically about his conflict of interest with Boston Consulting Group since 2006:

“To me it would seem as if you were still with this company and you still had this conflict of interest, and that is not the case since 2006?”

To which Blaxill replied by emphatically denying possession of any conflict of interest:

“Curt, I don’t have a conflict of interest of any kind now, and I have not had one for years. I haven’t had a conflict since I started the Age of Autism with JB Handley and Dan Olmsted and Kim Stagliano back in 2007. I haven’t had a conflict since I wrote the book The Age of Autism. I haven’t had a conflict since starting the Canary Party. The only time I had a conflict was when I was helping David Kirby and contributing to the Evidence of Harm book. And it’s even in the book, Curt; I have never hid the conflict. I’ve actually been public with people and open with people about the concerns I’ve had. So it’s not as though there is any great secrets I was keeping. And whatever concern I had, it is not operative any longer.”

However, Blaxill remains a board member of the Initiative for a Competitive Inner City (ICIC), which has received over $25,000 annually from Boston Consulting Group. Serving on the board with him is none other than Boston Consulting Group’s Chairman of the Board Carl Stern.

ICIC’s chairman and founder as well as Harvard Business School Prof. Michael Porter was thanked in no uncertain terms in the acknowledgements section of the book Blaxill coauthored in 2009 with his business partner Ralph Eckardt, “The Invisible Edge: Taking Your Strategy to the Next Level Using Intellectual Property:

“[The Boston Consulting Group Founder’s] ideas have been extended and enriched by the academic and consulting community in Boston, most notably by Harvard Business School Professor Michael Porter, on one hand, and our former colleagues at BCG on another.”

Blaxill and Eckardt then summed up their relationship with Prof. Porter as follows:

“Michael Porter has been a teacher, a collaborator, a client, and a friend.” 

It seems Blaxill and Eckardt are not the only ones with high praise for Prof. Porter. When Porter was awarded a prestigious University Professorship at Harvard, Merck’s then-chairman, president and CEO Raymond Gilmartin (who later resigned over the Vioxx scandal and became a Harvard Business School Professor himself) told the Harvard Gazette:

“Through his research, teaching, and writing, Mike Porter has made an indelible mark on businesses and markets everywhere. His leading-edge research has directly influenced the strategies and competitiveness of individual firms and the nation. More recently, he has helped to identify the key drivers of innovation, which has now become the basis of global competition. His insights are directly relevant to understanding the vital ingredients for success in a host of industries, including pharmaceuticals.”

Clearly Blaxill has much to gain by serving on ICIC’s board of directors with his former employer BCG’s Chairman of the Board while under Prof. Porter’s chairmanship. ICIC’s website boasts that the organization’s partners “gain as well as give.” It’s hard to fathom how Blaxill could honestly claim on Linderman to not possess a conflict of interest “of any kind.”

But Blaxill was not even honest in the Linderman interview about what he did during his past employment for BCG. He claimed:

“…I always worked with industrial companies, automotive, forest products, computers-type companies, but they also had pharmaceutical clients.”

But he did not solely work with those companies, because Blaxill consulted for Merck directly as a BCG employee himself. In 2010, he told me he had visited Merck’s headquarters in Whitehouse Station, New Jersey. Later at a 2011 gathering in Waltham, Massachusetts, where Blaxill announced his preliminary plans to found the Canary Party – I overheard him telling someone about his experience consulting for Merck, describing his former clients as “not that smart.”

Despite suggesting his departure from Boston Consulting Group was some sort of martyrdom for his autism advocacy and that he no longer has any ties to the firm, it appears that Mark Blaxill was not fired, but left on his own terms wholly unrelated to autism and even remains connected to his former employer who continues to serve pharmaceutical clients.

Jake Crosby is editor of Autism Investigated and is diagnosed with an autism spectrum disorder. He is a 2011 graduate of Brandeis University with a Bachelor of Arts in both History and Health: Science, Society and Policy and a 2013 graduate of The George Washington University School of Public Health and Health Services with a Master of Public Health in Epidemiology. He currently attends the University of Texas School of Public Health where he is studying for a Ph.D. in Epidemiology.

Autism Investigated Announces Awards for 2013

dreamstime_s_34849450

On New Year’s Eve, Autism Investigated announces its awards for 2013 looking back on the highlights of the year and the lessons learned – an award for each of five categories listed below. As I told one reader:

“2012 was a year of blissful ignorance whereas 2013 was a year of hard lessons – they were not easy to learn, but I think we will all be better off because of them. Here’s to an enlightened new year.”

I feel this sentiment is very strongly reflected in Autism Investigated’s awards for this year – a year when Autism Investigated only existed for the second half, but an eventful year nonetheless.

So here they are: Autism Investigated’s Awards for 2013!

Scientist of the Year: Dr. Brian Hooker

A researcher, professor, parent and advocate, Dr. Brian Hooker exemplifies scientific integrity, courage and persistence. Having organized the congressional hearing in 2012, Dr. Hooker works tirelessly to expose the scientific corruption of CDC and related groups that are implicated in the government cover-up of vaccines’ role in causing autism in children, especially vaccines containing the mercury-based, neurotoxic preservative thimerosal. He has made tremendous inroads with Congress despite overwhelming adversity, even from groups that claim to agree with his activities. Nonetheless, he remains unyielding in his pursuit of justice for countless vaccine-injured children, including his own son.

Thank you, Dr. Hooker!

Scoop of the Year: Mark Blaxill’s Early Interference in Autism Omnibus

blaxillwilliams

(Click to enlarge.)

Last October, Autism Investigated was sent email exchanges from 2003 and 2004 between members of SafeMinds and the lead petitioners’ attorney  in the autism omnibus proceeding for 4,900 children who developed autism after vaccination and were seeking federal compensation. The emails reveal that members of SafeMinds were being retained as consultants in the litigation. The email exchanges also reveal some troubling remarks by Mark Blaxill, then-board member of SafeMinds. Below are statements he has made in those emails to the attorney against petitioners’ expert witnesses Dr. Mark and David Geier as well as against suing in general. Also disturbing is his reference to his employer’s pharmaceutical clients.

Direct quotes from Mark Blaxill’s emails:

“The issue I will confess to the most difficulty with is the “sue the bastards” model…Please recognize, though, that my firm has clients on the other side and so I cannot–in fairness to my partners–get directly involved in the quest for money. I only am interested in the quest for the truth….I would say there are a few lawyers I’ve run into that make my discomfort really sharp.”

“As to the Geiers, I may be a bit of a minority voice here, but I worry very much that they can do our cause more harm than good. They are not very good scientists, write bad papers (both writing badly and reporting in sloppy fashion) and attract too much attention to themselves as individuals. In this last regard, they don’t show nearly as well as Andy Wakefield but they’re trying to play the same role. Frankly, if I were on the other side and were asked to critique their work, I could rip it to shreds. I’m surprised they haven’t been hit harder. So I think you are wise to diversify.”

I have not been a big fan of the Geiers. I worry they do not represent our side well. They often do sloppy work.”

In response to the last quote by Blaxill, the attorney replied:

“Thanks, Mark, very helpful.”

The autism omnibus eventually collapsed and thousands of children were denied justice. In a podcast interview last October, Mark Blaxill said he was not apologetic about anything he has done.

Quote of the Year: Dr. Boyd Haley on Mark Blaxill and the Geiers

After the above email passages were posted on Autism Investigated, emeritus chemistry professor, scientist and leading authority on mercury toxicity Dr. Boyd Haley responded in the below email:

I know both Mark Blaxill and Mark & David Geier fairly well. Mr. Blaxill does not have the biological science and medical training of the Geier’s and most of their articles address issues on the biological level. I have critically read most of the publications by the Geier’s and I seriously doubt that Mr. Blaxill could shred this research even though he may think he could.

Boyd E. Haley, PhD
President
CTI Science, Inc.

Irony of the Year: Tina Brown runs bogus autism-and-pedophilia-linking article, despite having son with autism.

Tinabrownson

Last August, The Daily Beast ran an article by Eustacia Cutler – mother of internationally famous autistic advocate and animal scientist Dr. Temple Grandin – falsely claiming autistic men have an affinity for pedophilia. Dr. Grandin distanced herself after the article was written following an inquiry by Autism Investigated. The major irony to emerge from this is that Tina Brown – editor of The Daily Beast – has an adult son with Asperger Syndrome, an autism spectrum disorder. She did not respond when confronted about the story on Twitter. The following month, Tina Brown stepped down as editor of The Daily Beast.

Event of the Year: NVICP Congressional Hearing Cancellation

Cancelled

The event of the year – or rather non-event of the year – goes to the cancellation of the congressional hearing on the National Vaccine Injury Compensation Program (NVICP). By asking Congress to investigate NVICP, Canary Party was able to prevent the CDC cover-up of vaccine dangers from gaining exposure in a congressional hearing despite the organization’s false promises to Dr. Brian Hooker that it would ask specifically for an investigation into the malfeasance. Then at a Canary Party Briefing held the month before the anticipated NVICP hearing, the case of vaccine-injured child Hannah Poling was misrepresented. After her mother Terry Poling protested in the comments of Age of Autism – the blog sponsored by Canary Party and edited by its chairman Mark Blaxill – Age of Autism took down the video of the briefing without explanation. After the incident was written about on Autism Investigated, Age of Autism claimed technical failure before finally re-uploading the video three days after its removal. That night, Autism Investigated received word that the December-scheduled NVICP congressional hearing that Canary Party was instrumental in lobbying for was cancelled. The reason, according to one reliable legal source, was that NVICP is an “overly divisive issue.”

Jake Crosby is editor of Autism Investigated and is diagnosed with an autism spectrum disorder. He is a 2011 graduate of Brandeis University with a Bachelor of Arts in both History and Health: Science, Society and Policy and a 2013 graduate of The George Washington University School of Public Health and Health Services with a Master of Public Health in Epidemiology. He currently attends the University of Texas School of Public Health where he is studying for a Ph.D. in Epidemiology.

Forbes’ Matt Herper Cites Misleading Gardasil Press Release

articleabstract

Editor’s Note: Above is the abstract of a study which was misrepresented by the drug company press release that Herper cited to endorse the cervical cancer vaccine Gardasil; click to enlarge.

By Jake Crosby

Mainstream media’s coverage of the disputed safety and effectiveness of human pappilloma virus (HPV) vaccination is a shameful repeat of its coverage of the vaccine-autism cover-up.

Following Katie Couric’s recent investigative report on the safety and efficacy of vaccination against HPV, many familiar media mouthpieces of the vaccine industry came out of the woodwork to chastise Couric for her journalism. Included among those was Matt Herper, senior editor of Forbes Magazine. Using Twitter to cite a press release from Gardasil’s manufacturer, Herper challenged HPV expert Dr. Diane Harper’s contention to Katie Couric that HPV vaccine Gardasil only provides protection for five years. His tweet:

It appears that the claim on @katiecouric that vaccine efficacy wanes at 5 years is incorrect. http://www.prnewswire.co.uk/news-releases/studies-demonstrate-gardasil-has-long-duration-of-protection-from-hpv-disease-182323031.html …

Herper’s tweet was retweeted dozens of times, including by vaccine industry media go-to guy Seth Mnookin. Herper also cited and linked to the drug company press release from his Forbes article attacking Couric for her program on Gardasil. According to the press release:

“The interim data, presented at the 28th International Papillomavirus Conference (IPV) in Puerto Rico, showed that young women[1] and adolescent girls and boys[2] vaccinated with Gardasil were protected from HPV-related diseases for up to eight years following vaccination.”

The press release also included quotes from Professor Susanne Krüger Kjær, lead investigator of one of the studies:

“These latest data show an encouraging trend of continued protection with Gardasil against HPV-related cervical, vaginal and vulvar disease in women through eight years,” said Professor Susanne Krüger Kjær, Danish Cancer Society. “These studies provide further evidence for the ongoing efficacy, immunogenicity, and safety of Gardasil.”

Absent from Sanofi Pasteur MSD’s press release, however, is the conclusion from Professor Kjær’s own study which reads:

“The qHPV vaccine shows a trend of continued protection in women, although there is as yet insufficient data to confirm that protection is maintained.”

If Matt Herper can go to the trouble of digging up a drug company press release from a year ago on research presented at a conference, then why couldn’t he go to the extra trouble to dig up the abstract of the actual research the press release was about? Why did he instead settle for the misleading press release written by a PR person employed by Gardasil’s manufacturer to second-guess the statements of Dr. Diane Harper – an international authority on HPV who was involved in clinical trials of Gardasil? Perhaps because the abstract would prove that the press release Herper cited is a misleading representation of research.

Herper’s use of a misleading drug company press release over actual research to push Gardasil is minor in comparison to his record of reporting on the vaccine-autism cover-up. He has endorsed Salon’s removal of “Deadly Immunity” by Robert F. Kennedy Jr. (which exposed CDC’s cover-up of the dangers of mercury in vaccines) prompted by a bogus rumor spread by Seth Mnookin that Rolling Stone Magazine secretly retracted Kennedy’s article. Salon is run by the brother-in-law of Arthur Allen, Mnookin’s predecessor as vaccine industry media go-to guy who vetted and ultimately approved of Mnookin’s since-dispelled rumor. So Matt Herper has a history of promoting scientific fraud to protect the vaccine industry. Even worse, such apologists now appear to dominate mainstream media’s coverage of vaccine safety issues, Katie Couric notwithstanding. Not surprisingly, Herper has not responded when informed on Twitter of what the actual research said.

Jake Crosby is editor of Autism Investigated and is diagnosed with an autism spectrum disorder. He is a 2011 graduate of Brandeis University with a Bachelor of Arts in both History and Health: Science, Society and Policy and a 2013 graduate of The George Washington University School of Public Health and Health Services with a Master of Public Health in Epidemiology. He currently attends the University of Texas School of Public Health where he is studying for a Ph.D. in Epidemiology.

NVICP Congressional Hearing Cancelled

Cancelled

By Jake Crosby

Unconfirmed reports by several reliable sources including an attorney have been brought to the attention of Autism Investigated. According to these reports, the congressional hearing on the National Vaccine Injury Compensation Program has been cancelled by the House Committee on Oversight & Government Reform chaired by Congressman Darrell Issa. This information comes after a vaccine-injured child’s case was misrepresented at a congressional briefing by Canary Party, video footage of which was removed along with an entire post from the Canary Party-sponsored Age of Autism blog.

After Autism Investigated reported on the deletion of the video, Age of Autism restored the post without the video, claiming technical difficulties. Then, after Autism Investigated posted a link to the video and an Age of Autism reader requested AoA also provide a link, the video was fully restored with the technical excuses scrubbed. Below is the NVICP hearing cancellation message from the attorney who gives insight into the reasons behind the cancellation:

“I was just informed by the Counsel for Chairman Issa that due to ‘great deal of reluctance about participating or being drawn into what they, in their private candid discussions with us, say they see as an overly divisive issue’ they are canceling the hearing.”

Autism Investigated will provide updates as this story develops. If confirmed, it will be a tragedy that direct interference by Canary Party and specifically Mark Blaxill led to the collapse of the hearing. Blaxill said on Linderman last month that Canary Party asked for hearings on NVICP instead of CDC malfeasance (as was falsely promised to autism parent and scientist Dr. Brian Hooker) because that was the topic Issa wanted. Yet now Issa is cancelling the hearing because of the divisiveness of the topic itself – the very topic Blaxill claimed Issa wanted to hold the hearing about.

This is not the first hearing Mark Blaxill hijacked. After news of last year’s hearing was leaked at the 2012 AutismOne conference, Blaxill and SafeMinds – the organization whose government affairs committee he had chaired – hired a lobbyist who misrepresented Dr. Brian Hooker to congressional staffers. Dr. Hooker originally organized the November hearing and succeeded in having Issa commit to holding hearings on autism causation and the vaccine program.

Yet through questionable lobbying activities, SafeMinds and Mark Blaxill effectively changed the topic of the hearing to the “federal response” enabling autism epidemic deniers to be invited to give testimony. Blaxill testified instead of Dr. Hooker and refused to discuss the fraudulent research defending thimerosal that Dr. Hooker had planned to testify about. But what can one expect when Blaxill cited Thorsen’s fraud to defend thimerosal in email to none other than Dr. Hooker? Blaxill’s excuse for not mentioning vaccines in his testimony was that he pulled a few punches to ensure another hearing was in the works, yet Issa had already committed to holding multiple hearings. And now Issa won’t hold the scheduled Dec. 4th hearing thanks to the topic Canary Party requested of Congress.

Rather than paving the way for a second congressional hearing, Mark Blaxill prevented a second congressional hearing altogether. At the first hearing, he told me:

“I don’t have a whole lot of hope.”

Blaxill’s prediction was a self-fulfilling prophecy.

For relevant posts on this sad saga, see below links beginning with most recent:

Age of Autism Deletes Canary Party Briefing Video

Mark Blaxill Defended Thimerosal With Fraudulent Danish Research

Mark Blaxill Admits COI When His Undermining Began

Listen to Jake Crosby on Linderman Unleashed

Mark Blaxill’s Early Interference in Autism Omnibus Revealed

Canary Party VP: “your judgement is compromised on this because of your autism”

How Dan Olmsted and David Kirby Helped Kill Landmark Autism Lawsuit

No More Federal Research Fraud – OPPOSE HR1757!

Age of Autism Condemned For Banishing Autism Investigated’s Editor

Mark Blaxill Publicly Attacks Critics

Outbound Links to other relevant articles:

SafeMinds Ignores Major Allegations While Replying Dishonestly to Other Charges – Age of Autism

SafeMinds Steals the Show, Literally… – Bolen Report

Jake Crosby is editor of Autism Investigated and is diagnosed with an autism spectrum disorder. He is a 2011 graduate of Brandeis University with a Bachelor of Arts in both History and Health: Science, Society and Policy and a 2013 graduate of The George Washington University School of Public Health and Health Services with a Master of Public Health in Epidemiology. He currently attends the University of Texas School of Public Health where he is studying for a Ph.D. in Epidemiology.